These hormones target the anterior pituitary gland, to make a disruption in its related hormones such as adrenocorticotropic hormone, antidiuretic hormone, follicle-stimulating hormone, growth hormone, luteinizing hormone, oxytocin, prolactin, and thyroid-stimulating hormone (82, 83)
Strength maintenance is achievable
However, this was just a pilot study with a small group of participants, so much more work is needed
This combination represents a promising therapeutic strategy for improving cardiovascular, renal, and metabolic outcomes in patients with T2DM
Weeks 13-16 : The dose increases again to 1.7 mg weekly
Users can expect to see initial results within days or weeks, with more significant transformations occurring over 3 to 6 months of consistent use